Search research articles
Contact Us
Filters
Showing results (41-50 of 195) with videos related to
Page
of 20
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 3, 2009
Advances in adjuvant chemotherapy for breast cancer: the role of taxanes
Virginia G Kaklamani, William J Gradishar
Current Oncology Reports
|
December 22, 2004
Hormonal therapy for primary breast cancer: scientific rationale and status of clinical research
Lisa E Sokolowicz, William J Gradishar
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2004
Evidence-based use of neoadjuvant taxane in operable and inoperable breast cancer
Laura G Estévez, William J Gradishar
Oncology (Williston Park, N.Y.)
|
July 10, 2020
Novel Neoadjuvant Treatment Strategies for Triple-Negative Breast Cancer
Andrew A Davis, William J Gradishar
Clinical Breast Cancer
|
February 11, 2017
Breast Cancer Outcomes After Diagnosis of Hormone-positive Breast Cancer and Subsequent Pregnancy in the Tamoxifen Era
Lauren Nye, Alfred Rademaker, William J Gradishar
Journal of Global Oncology
|
August 24, 2017
Differences Are Important: Breast Cancer Therapy in Different Ethnic Groups
Ricardo L B Costa, William J Gradishar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2021
Reply to S. Sorscher
Stephen R D Johnston, William J Gradishar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2018
Do Genomic Assays Provide the Necessary Confidence to De-escalate Adjuvant Therapy?
Ricardo L B Costa, William J Gradishar
JAMA Oncology
|
July 17, 2015
Changing Treatment Paradigms in Metastatic Breast Cancer: Lessons Learned
Cesar A Santa-Maria, William J Gradishar
Journal of Oncology Practice
|
May 11, 2017
Triple-Negative Breast Cancer: Current Practice and Future Directions
Ricardo L B Costa, William J Gradishar
Page
of 20
Search research articles
Search
Showing results (41-50 of 195) with videos related to
Sort By:
Page
of 20
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 3, 2009
Advances in adjuvant chemotherapy for breast cancer: the role of taxanes
Virginia G Kaklamani, William J Gradishar
Current Oncology Reports
|
December 22, 2004
Hormonal therapy for primary breast cancer: scientific rationale and status of clinical research
Lisa E Sokolowicz, William J Gradishar
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2004
Evidence-based use of neoadjuvant taxane in operable and inoperable breast cancer
Laura G Estévez, William J Gradishar
Oncology (Williston Park, N.Y.)
|
July 10, 2020
Novel Neoadjuvant Treatment Strategies for Triple-Negative Breast Cancer
Andrew A Davis, William J Gradishar
Clinical Breast Cancer
|
February 11, 2017
Breast Cancer Outcomes After Diagnosis of Hormone-positive Breast Cancer and Subsequent Pregnancy in the Tamoxifen Era
Lauren Nye, Alfred Rademaker, William J Gradishar
Journal of Global Oncology
|
August 24, 2017
Differences Are Important: Breast Cancer Therapy in Different Ethnic Groups
Ricardo L B Costa, William J Gradishar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2021
Reply to S. Sorscher
Stephen R D Johnston, William J Gradishar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2018
Do Genomic Assays Provide the Necessary Confidence to De-escalate Adjuvant Therapy?
Ricardo L B Costa, William J Gradishar
JAMA Oncology
|
July 17, 2015
Changing Treatment Paradigms in Metastatic Breast Cancer: Lessons Learned
Cesar A Santa-Maria, William J Gradishar
Journal of Oncology Practice
|
May 11, 2017
Triple-Negative Breast Cancer: Current Practice and Future Directions
Ricardo L B Costa, William J Gradishar
Page
of 20